Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Agonism and Antagonism: Quantification01:14

Agonism and Antagonism: Quantification

308
When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
308
Dose-Response Relationship: Overview01:03

Dose-Response Relationship: Overview

2.9K
Agonists can bind with and activate receptors, resulting in the formation of drug-receptor complexes. Once formed, these complexes catalyze many biochemical processes at the cellular level and subsequently induce a pharmacologic response. The degree of response is directly proportional to the fraction of activated receptors, which in turn, depends on the concentration of the drug at the receptor site as well as the sensitivity of the receptor. An increase in the administered dose contributes to...
2.9K
Drug Dosage Regimen: Overview01:15

Drug Dosage Regimen: Overview

3.4K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
3.4K
Dose-Response Relationship: Potency and Efficacy01:22

Dose-Response Relationship: Potency and Efficacy

4.2K
The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...
4.2K
Time Course of Drug Effect01:14

Time Course of Drug Effect

1.9K
The progression of a drug's impact can be analyzed by examining both the concentration-time course and the effect-time course. The concentration-time course is determined by the drug's half-life and is influenced by factors such as its pharmacokinetics, including absorption, distribution, metabolism, and elimination. The effect of the drug is often related to its concentration in the plasma and is calculated using the maximum drug effect and the plasma concentration that generates 50...
1.9K
Drug-Receptor Interactions01:29

Drug-Receptor Interactions

4.8K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
4.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A cytosolic class I small heat shock protein, RcHSP17.8, of Rosa chinensis confers resistance to a variety of stresses to Escherichia coli, yeast and Arabidopsis thaliana.

Plant, cell & environment·2009
Same author

Neuroprotective effects of Astragaloside IV in 6-hydroxydopamine-treated primary nigral cell culture.

Neurochemistry international·2009
Same author

[Clinical features of interstitial pneumonitis due to interferon alpha therapy for chronic hepatitis C].

Nan fang yi ke da xue xue bao = Journal of Southern Medical University·2009
Same author

Anti-hypoxic activity of the ethanol extract from Portulaca oleracea in mice.

Journal of ethnopharmacology·2009
Same author

[Effects of artemether and dihydroarteannuin on mouse model of scleroderma].

Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica·2009
Same author

Astragaloside IV attenuates cerebral ischemia-reperfusion-induced increase in permeability of the blood-brain barrier in rats.

European journal of pharmacology·2009
Same journal

Gabapentinoids for Neuropathic Pain Management: A Systematic Umbrella Review.

Current neuropharmacology·2026
Same journal

Spatial Transcriptomic Dissection of the Cellular and Molecular Architecture of Fear Memory and its Association with Memory Function.

Current neuropharmacology·2026
Same journal

Bridging Glial Cell Membrane Proteins and Mitochondria for Combating CNS Inflammatory and Neoplastic Diseases.

Current neuropharmacology·2026
Same journal

Exposure to Ketamine and 2-Fluorodeschloroketamine Impairs Mitochondrial Oxidative Phosphorylation in Human Cerebral Organoids: Implications for Neurodevelopmental Toxicity.

Current neuropharmacology·2026
Same journal

Regulated Cell Death and Neurological Diseases - Emerging Pathways and Therapeutic Implications.

Current neuropharmacology·2026
Same journal

Effects of Drugs for the Treatment of Multiple Sclerosis in Severe Acute Respiratory Syndrome Coronavirus 2 Infection on the Expression of Angiotensin-converting Enzyme 2 in vitro.

Current neuropharmacology·2026
See all related articles

Related Experiment Video

Updated: May 28, 2025

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

18.4K

Determining the Interaction in a Drug Combination using the Dose-based or Effect-based Method.

Tinghe Yu1, Tianyan Yu2, Xinya Li1

  • 1Laboratory of Obstetrics and Gynecology, Second Affiliated Hospital, Chongqing Medical University, Chongqing, China.

Current Neuropharmacology
|February 12, 2025
PubMed
Summary
This summary is machine-generated.

Chou

Keywords:
Chou’s methodDrug combinationJin’s methodcombination indexdose-effectprodrug-enzyme therapy.

More Related Videos

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
15:04

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Published on: January 19, 2019

12.1K
Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations
11:15

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations

Published on: July 24, 2021

4.5K

Related Experiment Videos

Last Updated: May 28, 2025

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

18.4K
Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
15:04

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Published on: January 19, 2019

12.1K
Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations
11:15

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations

Published on: July 24, 2021

4.5K

Area of Science:

  • Pharmacology
  • Drug Interactions
  • Quantitative Pharmacology

Background:

  • Assessing drug combinations is crucial for optimizing therapeutic outcomes.
  • Two primary methods, Chou's (CI-C) and Jin's (CI-J), evaluate drug interactions.
  • CI-C relies on dose-dependency, while CI-J focuses on effect-dependency.

Purpose of the Study:

  • To investigate the relationship between Chou's combination index (CI-C) and Jin's combination index (CI-J).
  • To establish the functional equivalence of 1/CI-C and CI-J in drug interaction assessment.
  • To propose a combined approach for more reliable drug interaction evaluation.

Main Methods:

  • Analysis of both simulated and released experimental data.
  • Calculation of Chou's combination index (CI-C) based on drug doses.
  • Calculation of Jin's combination index (CI-J) based on drug effects.

Main Results:

  • A significant correlation was observed between the inverse of Chou's index (1/CI-C) and Jin's index (CI-J).
  • The findings demonstrate that 1/CI-C and CI-J are functionally equivalent for assessing drug interactions.
  • Consistency between the two indices provides a reliable assessment, while discrepancies necessitate further investigation.

Conclusions:

  • The inverse of Chou's combination index (1/CI-C) and Jin's combination index (CI-J) are functionally equivalent.
  • Combining both indices enhances the reliability of drug interaction assessments.
  • Further analysis is required when inconsistencies arise between the two methods, particularly with released data.